EUVIMEDEUVIMED entdecken
Crossref

Outcomes of Coronary Artery By-Pass Grafting Under Dual Antiplatelet Therapy in ST Elevated Myocardial Infarction

Gokturk Ipek iD, Tamer Kehlibar, Muhammed Keskin iD, Hale Yilmaz, Bulent Ketenci, Osman Bolca

Angiology · 2023-04 · 74 (4) · 374-380

DOI: 10.1177/00033197221110696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angiology, online erschienen am 22.06.2022. Verfasst von Gokturk Ipek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, RinggolID: 111319SiyamiErsek Cardiothoracic Surgery Center, Istanbul, Turkey. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with recent myocardial infarction (MI) or percutaneous coronary interventions (PCI) have a higher ischemic risk in addition to perioperative bleeding risk when undergoing coronary artery bypass grafting (CABG). Data regarding preoperative dual antiplatelet therapy (DAPT) failed to create a clear recommendation. In the present study, we assessed the relationship between preoperative DAPT use and adverse outcomes, particularly in ST-elevation MI (STEMI) patients. We retrospectively analyzed 748 consecutive patients with STEMI who underwent subsequent CABG surgery. Patients were divided into 2 groups: those on DAPT up to the day before CABG and those discontinued DAPT >5 days before CABG. Predictors of in-hospital mortality and major bleeding were analyzed by multivariate analysis. Preoperative DAPT was not associated with in-hospital mortality (Odds Ratio (OR):1.81; 95% Confidence Interval (CI): .89-3.68, P = .10) and major bleeding (OR: 1.15; 95% CI: .63-2.08, P = .65) after multivariate analysis. However, glycoprotein (Gp) 2b/3a inhibitors were independently associated with higher major bleeding rates. Age, shock, and EF (ejection fraction)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ST Elevation Myocardial InfarctionPercutaneous Coronary InterventionHumansPlatelet Aggregation InhibitorsCoronary VesselsRetrospective StudiesTreatment OutcomeHemorrhage

Stichwörter der Autor:innen

ST-elevation myocardial infarctionbleedingcoronary artery bypass graftingdual antiplatelet therapymortality

Substanzen

Platelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Cardiology, RinggolID: 111319SiyamiErsek Cardiothoracic Surgery Center, Istanbul, Turkey.
  • Department of Cardiovascular Surgery, RinggolID: 111319SiyamiErsek Cardiothoracic Surgery Center, Istanbul, Turkey.

ORCID-Profile: Gokturk Ipek, Muhammed Keskin

Zitieren

APA

Ipek, G., Kehlibar, T., Keskin, M., Yilmaz, H., Ketenci, B., & Bolca, O. (2023). Outcomes of Coronary Artery By-Pass Grafting Under Dual Antiplatelet Therapy in ST Elevated Myocardial Infarction. Angiology, 74(4), 374-380. https://doi.org/10.1177/00033197221110696

Vancouver

Ipek G, Kehlibar T, Keskin M, Yilmaz H, Ketenci B, Bolca O. Outcomes of Coronary Artery By-Pass Grafting Under Dual Antiplatelet Therapy in ST Elevated Myocardial Infarction. Angiology. 2023;74(4):374-380. doi:10.1177/00033197221110696

BibTeX
@article{Ipek2023,
  author = {Ipek, Gokturk and Kehlibar, Tamer and Keskin, Muhammed and Yilmaz, Hale and Ketenci, Bulent and Bolca, Osman},
  title = {Outcomes of Coronary Artery By-Pass Grafting Under Dual Antiplatelet Therapy in ST Elevated Myocardial Infarction},
  journal = {Angiology},
  year = {2023},
  volume = {74},
  number = {4},
  pages = {374--380},
  doi = {10.1177/00033197221110696}
}
Kostenlos starten →